Biopharmaceutics & drug disposition

· 3 papers in corpus
other 2022
doi:10.1002/bdd.2315 ·PMID:35405765

The aim of this analysis was to use a physiologically based pharmacokinetic (PBPK) model to predict the impact of changes in dissolution rates on elagolix exposures and define clinically relevant acceptance criteria for dissolution. Varying…

other 1991
doi:10.1002/bdd.2510120204 ·PMID:2031992

Nimesulide is a non-steroidal anti-inflammatory agent which has proved to be effective in reducing menstrual discomfort in dysmenorrhoeaic women. To determine the concentrations of this drug in the uterus (fundus, cervix), oviduct, and ovar…

rct 1991
doi:10.1002/bdd.2510120804 ·PMID:1801964

A comparative bioavailability study was conducted with two capsule formulations of danazol (200 mg) in 16 healthy adult male volunteers. Fasting subjects received single doses (400 mg) of each formulation on separate occasions 1 week apart.…